However, whether Paxillin concentration at the MTJ is disrupted in zebrafish models of secondary dystroglycanopathy and whether Paxillin overexpression ameliorates muscle degeneration in zebrafish models of secondary dystroglycanopathy have not been investigated. Here, PXN is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.